Gallant Raises $15M for Pet Stem Cell Therapies
01/30/24, 1:45 PM
Location
san diegoMoney raised
$15 million
Industry
therapeutics
biotechnology
health care
Investors
Digitalis Ventures
Gallant Therapeutics announced it had raised more than $15 million in Series A funding from a leading investor syndicate, enabling the company to further its mission to make U.S. Food and Drug Administration-approved, stem cell therapies a reality for pets.
Company Info
Location
12130 millennium drive
san diego, california, united states
Additional Info
Gallant Therapeutics is a San Diego-based full-development clinical stage animal health biotechnology company that is pioneering ready-to-use stem cell therapies for pets, with the potential to transform pet diseases by re-establishing the normal biological function of tissues and organs.